Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

2.

Use of an automated decision support tool optimizes clinicians' ability to interpret and appropriately respond to structured self-monitoring of blood glucose data.

Rodbard HW, Schnell O, Unger J, Rees C, Amstutz L, Parkin CG, Jelsovsky Z, Wegmann N, Axel-Schweitzer M, Wagner RS.

Diabetes Care. 2012 Apr;35(4):693-8. doi: 10.2337/dc11-1351. Epub 2012 Feb 16.

3.

The impact of blood glucose monitoring on depression and distress in insulin-naïve patients with type 2 diabetes.

Fisher L, Polonsky W, Parkin CG, Jelsovsky Z, Amstutz L, Wagner RS.

Curr Med Res Opin. 2011 Nov;27 Suppl 3:39-46. doi: 10.1185/03007995.2011.619176. Epub 2011 Sep 14.

PMID:
21916532
4.

The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with Type 2 Diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986].

Polonsky W, Fisher L, Schikman C, Hinnen D, Parkin C, Jelsovsky Z, Amstutz L, Schweitzer M, Wagner R.

BMC Fam Pract. 2010 May 18;11:37. doi: 10.1186/1471-2296-11-37.

5.

Subcellular localization of glutaraldehyde.

Ranly DM, Amstutz L, Horn D.

Endod Dent Traumatol. 1990 Dec;6(6):251-4.

PMID:
2128827
6.

Long-latency event-related potentials in the evaluation of cognitive function in children.

Finley WW, Faux SF, Hutcheson J, Amstutz L.

Neurology. 1985 Mar;35(3):323-7.

PMID:
3974890

Supplemental Content

Loading ...
Support Center